Author:
Jacobi J.,Schmieder Roland E.
Reference101 articles.
1. Anderton JL, Gill M, Nothgi A (1994) Renal hemodynamic effects of bunazosin and prazosin in mild to moderately hypertensive patients with normal to moderately impaired renal function. Nephrol Dial Transplant 9: 607–612
2. Bakris GL, Bamhill BW, Sadler R (1992) Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection. Kidney Int 41: 912–919
3. Bakris GL, Williams B (1995) Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: Does the progression diabetic renal disease differ? J Hypertens 13 (suppl. 2): S95–101
4. Baylis C, Qiu C (1996) Importance of nitric oxide in the control of renal hemodynamics. Kidney Int 49: 1727–1731
5. Bech JN, Nielsen B, Pedersen B (1996) Effects of systemic NO synthesis inhibition on RPE GFR, UNa, and vasoactive hormones in healthy humans. Am J Physiol 270: F845-F851